DK0759302T3 - Middel mod rheumatoid arthritis - Google Patents
Middel mod rheumatoid arthritisInfo
- Publication number
- DK0759302T3 DK0759302T3 DK95913319T DK95913319T DK0759302T3 DK 0759302 T3 DK0759302 T3 DK 0759302T3 DK 95913319 T DK95913319 T DK 95913319T DK 95913319 T DK95913319 T DK 95913319T DK 0759302 T3 DK0759302 T3 DK 0759302T3
- Authority
- DK
- Denmark
- Prior art keywords
- remedy
- rheumatoid arthritis
- monoclonal antibody
- antibody recognizing
- arthritis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8825194 | 1994-04-26 | ||
PCT/JP1995/000527 WO1995028961A1 (fr) | 1994-04-26 | 1995-03-22 | Medicament pour polyarthrite rhumatoide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0759302T3 true DK0759302T3 (da) | 2000-11-13 |
Family
ID=13937651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95913319T DK0759302T3 (da) | 1994-04-26 | 1995-03-22 | Middel mod rheumatoid arthritis |
Country Status (9)
Country | Link |
---|---|
US (1) | US5855888A (da) |
EP (1) | EP0759302B1 (da) |
AT (1) | ATE195428T1 (da) |
DE (1) | DE69518415T2 (da) |
DK (1) | DK0759302T3 (da) |
ES (1) | ES2151054T3 (da) |
GR (1) | GR3034200T3 (da) |
PT (1) | PT759302E (da) |
WO (1) | WO1995028961A1 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE347907T1 (de) * | 1998-10-07 | 2007-01-15 | Lennart Lindbom | Anti-entzündliche alpha2, beta1 integrin- verwandte substanzen oder antikörper |
HU226383B1 (hu) * | 1999-04-22 | 2008-10-28 | Biogen Idec Inc | Eljárás fibrózis kezelésére az integrin alfa-4-alegységének antagonistájával |
CN1309419C (zh) * | 1999-06-01 | 2007-04-11 | 比奥根艾迪克Ma公司 | Vla-1的单克隆封闭抗体及其应用 |
US6146639A (en) * | 1999-07-26 | 2000-11-14 | Merich Nick | Arthritis, muscle pain, and dry skin remedy |
DE60236735D1 (de) | 2001-04-13 | 2010-07-29 | Biogen Idec Inc | Antikörper gegen vla-1 |
US20030013107A1 (en) * | 2001-06-07 | 2003-01-16 | Rigel Pharmaceuticals, Incorporated | Alpha 2 integrin: modulators of lymphocyte activation |
AP2809A (en) * | 2005-11-18 | 2013-12-31 | Glenmark Pharmaceuticals Sa | Anti-Alpha2 Integrin antibodies and their uses |
EP2839843B1 (en) * | 2006-05-25 | 2018-06-20 | Biogen MA Inc. | VLA-1 antagonist for use in treating stroke |
US20080267978A1 (en) * | 2006-08-28 | 2008-10-30 | Mary Zutter | Anti-angiogenic targets for cancer therapy |
AU2012255143A1 (en) | 2011-05-19 | 2014-02-20 | The Regents Of The University Of Michigan | Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation |
EP2814468B1 (en) | 2012-02-16 | 2019-06-19 | Santarus, Inc. | Anti-vla1 (cd49a) antibody pharmaceutical compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0330506A3 (en) * | 1988-02-26 | 1990-06-20 | Dana Farber Cancer Institute | Vla proteins |
DK162890D0 (da) * | 1990-07-06 | 1990-07-06 | Novo Nordisk As | Polypeptid |
AU673499B2 (en) * | 1991-07-25 | 1996-11-14 | Biogen Idec Inc. | Recombinant antibodies for human therapy |
-
1995
- 1995-03-22 US US08/727,406 patent/US5855888A/en not_active Expired - Fee Related
- 1995-03-22 PT PT95913319T patent/PT759302E/pt unknown
- 1995-03-22 ES ES95913319T patent/ES2151054T3/es not_active Expired - Lifetime
- 1995-03-22 EP EP95913319A patent/EP0759302B1/en not_active Expired - Lifetime
- 1995-03-22 DE DE69518415T patent/DE69518415T2/de not_active Expired - Fee Related
- 1995-03-22 DK DK95913319T patent/DK0759302T3/da active
- 1995-03-22 WO PCT/JP1995/000527 patent/WO1995028961A1/ja active IP Right Grant
- 1995-03-22 AT AT95913319T patent/ATE195428T1/de not_active IP Right Cessation
-
2000
- 2000-08-17 GR GR20000401715T patent/GR3034200T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2151054T3 (es) | 2000-12-16 |
GR3034200T3 (en) | 2000-11-30 |
ATE195428T1 (de) | 2000-09-15 |
DE69518415T2 (de) | 2001-01-25 |
PT759302E (pt) | 2001-01-31 |
EP0759302B1 (en) | 2000-08-16 |
DE69518415D1 (de) | 2000-09-21 |
WO1995028961A1 (fr) | 1995-11-02 |
EP0759302A4 (en) | 1997-11-19 |
US5855888A (en) | 1999-01-05 |
EP0759302A1 (en) | 1997-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0759302T3 (da) | Middel mod rheumatoid arthritis | |
ITMI921522A0 (it) | Apparato di lavaggio e sterilizzazione di tappi di gomma, o simili impiegabili in confezioni farmaceutiche | |
FI932958A (fi) | Elastisk paose foer att packa in sammantryckbara produkter, speciellt sanitetsartiklar saosom bloejor, samt en foerpackning i vilken sammantryckta sanitetsprodukter foerpackats | |
NL300098I1 (nl) | Thiophene sulfonamides useful as carbonic anhydrase inhibitors. | |
FI935443A (fi) | Kabeltaetning | |
ATE138569T1 (de) | Topisch anzuwendendes arzneimittel enthaltend ketoprofenlysinat | |
FI893159A (fi) | Laite ja menetelmä terveydenhuollossa syntyvien ongelmajätteiden käsittelemiseksi | |
ATE113650T1 (de) | Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen. | |
ES2145158T3 (es) | Nueva formulacion de emulsion. | |
ZA969130B (en) | Diagnostics and treatments of periodontal disease | |
BR9406292A (pt) | Complexo de inclusão de taxol ou taxotere ou extrato de taxus formados com ciclodextrinas sua preparação e uso | |
ATE433339T1 (de) | Parasympathikomimetikum und parasympathikolytikum enthaltendes tts | |
DE59104380D1 (de) | Vorrichtung zum Bilden von Reihen und Lagen von Flaschen. | |
YU49422B (sh) | Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću | |
ATE139226T1 (de) | Aminosulfonylharnstoff-acat-inhibitoren | |
TNSN95055A1 (fr) | Un article absorbant jetable-methode et appareillage pour sa fabrication | |
DK1146043T3 (da) | Taxaner med en alkylsubstitueret sidekæde og farmaceutiske præparater indeholdende disse | |
FR2713444B1 (fr) | Composition liquide désinfectante et ses utilisations. | |
ITRM910545A0 (it) | Dispositivo trasportatore di bobine, rocche di filo e simili | |
ES2187618T3 (es) | Utilizacion de compuestos de urea y de tiourea para la eliminacion o desintoxicacion de superantigenos de fluidos corporales. | |
KR950701812A (ko) | 렌티바이러스-유도된 질환의 치료에 유용한 생물학적으로 활성인 우레이도 유도체(Biologically active ureido dervatives useful in the treatment of lentivirus-induced sisease) | |
ATE222255T1 (de) | 14-substituierte marcfortine und derivate als antiparasitäre mittel | |
FR2690330B1 (fr) | Dispositif destine a traiter certaines fractures siegeant entre massif trochanterien et 1/3 moyen de la diaphyse femorale. | |
DK0826373T3 (da) | Forebyggende middel mod postoperativ astigmatisme | |
ATE136469T1 (de) | Neue verwendung eines monoklonalen antikörpers |